{"transactions":[{"id":1430933,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-16T16:05:06.000Z","date":"2024-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":70883,"price":0.67,"value":47491.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested restricted stock units."}],"balance_after":1468609,"source":{"system":"sec-edgar","filing":"0000950170-24-098048","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017024098048/ownership.xml","form_type":"4"}},{"id":1640612,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-02-15T16:05:07.000Z","date":"2024-02-15","kind":"grant","planned":false,"acquired":true,"shares":819000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 819,000 restricted stock units, 25% of which will vest on February 15, 2025, with the remaining shares vesting in equal semi-annual installments through February 15, 2028, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":1539492,"source":{"system":"sec-edgar","filing":"0000950170-24-015858","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017024015858/ownership.xml","form_type":"4"}},{"id":1802955,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-17T16:21:01.000Z","date":"2023-08-15","kind":"grant","planned":false,"acquired":true,"shares":559450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of 559,450 restricted stock units, 25% of which will vest on August 15, 2024, with the remaining shares vesting in equal semi-annual installments through August 15, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":720492,"source":{"system":"sec-edgar","filing":"0000950170-23-043221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023043221/ownership.xml","form_type":"4"}},{"id":1802954,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-08-17T16:21:01.000Z","date":"2023-08-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":117881,"price":3.14,"value":370146.34,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs."}],"balance_after":161042,"source":{"system":"sec-edgar","filing":"0000950170-23-043221","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023043221/ownership.xml","form_type":"4"}},{"id":1888399,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-05-17T16:54:04.000Z","date":"2023-05-15","kind":"tax_withholding","planned":false,"acquired":false,"shares":11249,"price":3.35,"value":37684.15,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs."}],"balance_after":278923,"source":{"system":"sec-edgar","filing":"0000950170-23-022770","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000095017023022770/ownership.xml","form_type":"4"}},{"id":1945961,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-17T21:18:57.000Z","date":"2023-03-15","kind":"tax_withholding","acquired":false,"shares":22252,"price":2.56,"value":56965.12,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of vested RSUs."}],"balance_after":290172,"source":{"system":"sec-edgar","filing":"0000899243-23-009035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323009035/doc4.xml","form_type":"4"}},{"id":1945960,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-17T21:18:57.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":44879,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of 44,879 RSUs, which vested upon grant."}],"balance_after":312424,"source":{"system":"sec-edgar","filing":"0000899243-23-009035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323009035/doc4.xml","form_type":"4"}},{"id":1945959,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-03-17T21:18:57.000Z","date":"2023-03-15","kind":"grant","acquired":true,"shares":155550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 155,550 restricted stock units (\"RSUs\"), 25% of which will vest on May 15, 2024, with the remaining shares vesting in equal semi-annual installments through May 15, 2027, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":267545,"source":{"system":"sec-edgar","filing":"0000899243-23-009035","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323009035/doc4.xml","form_type":"4"}},{"id":2061732,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Series X Preferred Stock","published_at":"2023-01-05T16:06:00.000Z","date":"2023-01-03","kind":"disposition_to_issuer","acquired":false,"shares":178,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On November 10, 2022, the Company's board of directors (the \"Board\") declared a dividend of one one-thousandth of a share of Series X Preferred Stock, par value $0.001 per share (the \"Preferred Stock\"), for each outstanding share of common stock to common stockholders of record at 5:00 p.m. Eastern Time on November 21, 2022, in a transaction exempt from Section 16 under Rule 16a-9. The shares of Preferred Stock were distributed on November 21, 2022. As a result, the Reporting Person received the shares of Preferred Stock set forth above. The Preferred Stock was not convertible into, or exchangeable for, shares of any other class or series of stock or other securities of the Company."},{"field":"shares","element":"transactionShares","label":"F2","text":"On January 3, 2023, in connection with the Company's reverse stock split for the common stock, the shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation of the Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.001 in cash (rounded to the nearest cent) for each whole share of Preferred Stock."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"On January 3, 2023, in connection with the Company's reverse stock split for the common stock, the shares of Preferred Stock were redeemed automatically in accordance with the certificate of designation of the Preferred Stock. Each share of Preferred Stock was redeemed in consideration for the right to receive an amount equal to $0.001 in cash (rounded to the nearest cent) for each whole share of Preferred Stock."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-23-000967","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924323000967/doc4.xml","form_type":"4"}},{"id":2114081,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-11-16T21:48:41.000Z","date":"2022-11-15","kind":"tax_withholding","acquired":false,"shares":175071,"price":0.27,"value":47269.17,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares withheld by the Issuer to satisfy tax withholding obligations in connection with the release of 353,107 vested restricted stock units on November 15, 2022."}],"balance_after":2799858,"source":{"system":"sec-edgar","filing":"0000899243-22-036078","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322036078/doc4.xml","form_type":"4"}},{"id":2267398,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-05-17T17:19:35.000Z","date":"2022-05-15","kind":"grant","acquired":true,"shares":2495425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F2","text":"This option represents the right to purchase 2,495,425 shares of the Issuer's common stock, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal monthly installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 2,495,425 shares of the Issuer's common stock, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal monthly installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":2495425,"derivative":{"exercise_price":0.75,"expiration_date":"2032-05-15","underlying":"Common Stock","underlying_shares":2495425},"source":{"system":"sec-edgar","filing":"0000899243-22-018429","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322018429/doc4.xml","form_type":"4"}},{"id":2267397,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2022-05-17T17:19:35.000Z","date":"2022-05-15","kind":"grant","acquired":true,"shares":1562500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of 1,562,500 restricted stock units, 25% of which will vest on May 15, 2023, with the remaining shares vesting in equal semi-annual installments through May 15, 2026, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":2974929,"source":{"system":"sec-edgar","filing":"0000899243-22-018429","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924322018429/doc4.xml","form_type":"4"}},{"id":2512312,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-11-15T19:34:38.000Z","date":"2021-11-08","kind":"grant","acquired":true,"shares":2086898,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"deemedExecutionDate","element":"deemedExecutionDate","label":"F2","text":"This option represents the right to purchase 2,086,898 shares of the Issuer's common stock, 25% of which will vest on November 8, 2022, with the remaining shares vesting in equal monthly installments through November 8, 2025, subject to the Reporting Person's continued service to the Issuer."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"This option represents the right to purchase 2,086,898 shares of the Issuer's common stock, 25% of which will vest on November 8, 2022, with the remaining shares vesting in equal monthly installments through November 8, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":2086898,"derivative":{"exercise_price":3.54,"expiration_date":"2031-11-08","underlying":"Common Stock","underlying_shares":2086898},"source":{"system":"sec-edgar","filing":"0000899243-21-044665","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321044665/doc4.xml","form_type":"4"}},{"id":2512311,"issuer":{"id":85047,"kind":"organization","name":"BIORA THERAPEUTICS, INC.","symbol":"BIOR"},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2021-11-15T19:34:38.000Z","date":"2021-11-08","kind":"grant","acquired":true,"shares":1412429,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents 1,412,429 restricted stock units, 25% of which will vest on November 15, 2022, with the remaining shares vesting in equal semi-annual installments through November 15, 2025, subject to the Reporting Person's continued service to the Issuer."}],"balance_after":1412429,"source":{"system":"sec-edgar","filing":"0000899243-21-044665","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1580063/000089924321044665/doc4.xml","form_type":"4"}},{"id":3458595,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-07-19T20:31:17.000Z","date":"2019-07-17","kind":"grant","acquired":true,"shares":45000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":45000,"derivative":{"exercise_price":2.12,"expiration_date":"2029-07-16","underlying":"Common Stock","underlying_shares":45000},"source":{"system":"sec-edgar","filing":"0001209191-19-042847","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629819/000120919119042847/doc4.xml","form_type":"4"}},{"id":3628403,"issuer":{"id":6631,"kind":"organization","name":"Insight Molecular Diagnostics Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Option to Purchase Common Stock","published_at":"2019-02-27T21:56:53.000Z","date":"2019-02-15","kind":"grant","acquired":true,"shares":33750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Options shall vest one year from the date of grant, subject to the director's continued service as a director of the Company or a subsidiary from the date of grant until the vesting date or, if earlier, until the next annual meeting of shareholders."}],"balance_after":33750,"derivative":{"exercise_price":3.8,"expiration_date":"2029-02-14","underlying":"Common Stock","underlying_shares":33750},"source":{"system":"sec-edgar","filing":"0001209191-19-014338","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1629819/000120919119014338/doc4.xml","form_type":"4"}},{"id":3868950,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-07-12T23:45:54.000Z","date":"2018-07-10","kind":"exercise","acquired":false,"shares":4687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on July 10, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on July 10, 2018."}],"balance_after":32813,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":4687},"source":{"system":"sec-edgar","filing":"0001209191-18-042492","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118042492/doc4.xml","form_type":"4"}},{"id":3868949,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-07-12T23:45:54.000Z","date":"2018-07-10","kind":"tax_withholding","acquired":false,"shares":1621,"price":2.2,"value":3566.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,687 Restricted Stock Units, the grant of which\nwas previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 32,813 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":101384,"source":{"system":"sec-edgar","filing":"0001209191-18-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118042492/doc4.xml","form_type":"4"}},{"id":3868948,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-07-12T23:45:54.000Z","date":"2018-07-10","kind":"exercise","acquired":true,"shares":4687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 32,813 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":103005,"source":{"system":"sec-edgar","filing":"0001209191-18-042492","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118042492/doc4.xml","form_type":"4"}},{"id":3965017,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-04-13T00:39:21.000Z","date":"2018-04-10","kind":"exercise","acquired":false,"shares":4688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on April 10, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on April 10, 2018."}],"balance_after":37500,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":4688},"source":{"system":"sec-edgar","filing":"0001209191-18-024789","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118024789/doc4.xml","form_type":"4"}},{"id":3965016,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-04-13T00:39:21.000Z","date":"2018-04-10","kind":"tax_withholding","acquired":false,"shares":1622,"price":2.49,"value":4038.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,688 Restricted Stock Units, the grant of which\nwas previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 37,500 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":98318,"source":{"system":"sec-edgar","filing":"0001209191-18-024789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118024789/doc4.xml","form_type":"4"}},{"id":3965015,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-04-13T00:39:21.000Z","date":"2018-04-10","kind":"exercise","acquired":true,"shares":4688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 37,500 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":99940,"source":{"system":"sec-edgar","filing":"0001209191-18-024789","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118024789/doc4.xml","form_type":"4"}},{"id":3990788,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Option to Purchase Common Shares","published_at":"2018-03-19T23:04:25.000Z","date":"2018-03-15","kind":"grant","acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One quarter of the options shall vest upon the completion of continuous service from the date of grant until February 1, 2019, and the balance of the options shall vest in 36 equal monthly installments, commencing on February 1, 2019, based upon continued service."}],"balance_after":200000,"derivative":{"exercise_price":2.54,"expiration_date":"2028-03-14","underlying":"Common Shares","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001209191-18-020724","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118020724/doc4.xml","form_type":"4"}},{"id":4100937,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2018-01-13T02:17:09.000Z","date":"2018-01-10","kind":"exercise","acquired":false,"shares":4687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on January 10, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on January 10, 2018."}],"balance_after":42188,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":4687},"source":{"system":"sec-edgar","filing":"0001209191-18-003498","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118003498/doc4.xml","form_type":"4"}},{"id":4100936,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-01-13T02:17:09.000Z","date":"2018-01-10","kind":"tax_withholding","acquired":false,"shares":2057,"price":2.68,"value":5512.76,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,687 Restricted Stock Units, the grant of which\nwas previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 42,188 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":95252,"source":{"system":"sec-edgar","filing":"0001209191-18-003498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118003498/doc4.xml","form_type":"4"}},{"id":4100935,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2018-01-13T02:17:09.000Z","date":"2018-01-10","kind":"exercise","acquired":true,"shares":4687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 42,188 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":97309,"source":{"system":"sec-edgar","filing":"0001209191-18-003498","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919118003498/doc4.xml","form_type":"4"}},{"id":4187646,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-10-13T01:35:31.000Z","date":"2017-10-10","kind":"exercise","acquired":false,"shares":4688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on October 10, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on October 10, 2017."}],"balance_after":46875,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":4688},"source":{"system":"sec-edgar","filing":"0001209191-17-056783","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117056783/doc4.xml","form_type":"4"}},{"id":4187645,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-10-13T01:35:31.000Z","date":"2017-10-10","kind":"tax_withholding","acquired":false,"shares":1762,"price":2.81,"value":4951.22,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,688 Restricted Stock Units, the grant of which\nwas previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 46,875 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":92622,"source":{"system":"sec-edgar","filing":"0001209191-17-056783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117056783/doc4.xml","form_type":"4"}},{"id":4187644,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-10-13T01:35:31.000Z","date":"2017-10-10","kind":"exercise","acquired":true,"shares":4688,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 46,875 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":94384,"source":{"system":"sec-edgar","filing":"0001209191-17-056783","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117056783/doc4.xml","form_type":"4"}},{"id":4227943,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-08-23T00:22:42.000Z","date":"2017-08-21","kind":"purchase","acquired":true,"shares":7500,"price":2.5,"value":18750.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":89696,"source":{"system":"sec-edgar","filing":"0001209191-17-049877","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117049877/doc4.xml","form_type":"4"}},{"id":4258694,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-07-12T23:26:32.000Z","date":"2017-07-10","kind":"exercise","acquired":false,"shares":4687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on July 10, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on July 10, 2017."}],"balance_after":51563,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":4687},"source":{"system":"sec-edgar","filing":"0001209191-17-044963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117044963/doc4.xml","form_type":"4"}},{"id":4258693,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-07-12T23:26:32.000Z","date":"2017-07-10","kind":"tax_withholding","acquired":false,"shares":1762,"price":3.09,"value":5444.58,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 4,687 Restricted Stock Units, the grant of which\nwas previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 51,563 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":82196,"source":{"system":"sec-edgar","filing":"0001209191-17-044963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117044963/doc4.xml","form_type":"4"}},{"id":4258692,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-07-12T23:26:32.000Z","date":"2017-07-10","kind":"exercise","acquired":true,"shares":4687,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 51,563 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":83958,"source":{"system":"sec-edgar","filing":"0001209191-17-044963","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117044963/doc4.xml","form_type":"4"}},{"id":4288981,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Option to Purchase Common Shares","published_at":"2017-06-08T21:10:53.000Z","date":"2017-06-06","kind":"grant","acquired":true,"shares":650000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One quarter of the options shall vest upon the completion of continuous service from the date of grant until February 1, 2018, and the balance of the options shall vest in 36 equal monthly installments, commencing on February 1, 2018, based upon continued service."}],"balance_after":650000,"derivative":{"exercise_price":3.16,"expiration_date":"2027-06-05","underlying":"Common Shares","underlying_shares":650000},"source":{"system":"sec-edgar","filing":"0001209191-17-038596","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117038596/doc4.xml","form_type":"4"}},{"id":4340917,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2017-05-02T01:18:10.000Z","date":"2017-04-10","kind":"exercise","acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted Stock Units vested on April 10, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted Stock Units vested on April 10, 2017."}],"balance_after":56250,"derivative":{"exercise_price":0,"underlying":"Common Shares","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001209191-17-029051","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117029051/doc4.xml","form_type":"4"}},{"id":4340916,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-05-02T01:18:10.000Z","date":"2017-04-10","kind":"tax_withholding","acquired":false,"shares":7046,"price":3.33,"value":23463.18,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Securities withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 18,750 Restricted Stock Units, the grant of which\nwas previously reported on a Form 4."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 56,250 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":79271,"source":{"system":"sec-edgar","filing":"0001209191-17-029051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117029051/doc4.xml","form_type":"4"}},{"id":4340915,"issuer":{"id":6045,"kind":"organization","name":"Lineage Cell Therapeutics, Inc."},"owners":[{"id":88245,"kind":"person","name":"MOHANTY ADITYA P.","position":1,"cik":"0001629819","reported_name":"MOHANTY ADITYA P.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Co-Chief Executive Officer"}}],"security":"Common Shares, no par value","published_at":"2017-05-02T01:18:10.000Z","date":"2017-04-10","kind":"exercise","acquired":true,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Does not include 56,250 Restricted Stock Units payable in shares of the Issuer's common stock that have not vested as of the date of this Report and shares that may be acquired upon the exercise of certain stock options."}],"balance_after":86317,"source":{"system":"sec-edgar","filing":"0001209191-17-029051","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/876343/000120919117029051/doc4.xml","form_type":"4"}}]}